S. Chapet

2.2k total citations · 1 hit paper
48 papers, 1.3k citations indexed

About

S. Chapet is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, S. Chapet has authored 48 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 20 papers in Oncology and 19 papers in Surgery. Recurrent topics in S. Chapet's work include Head and Neck Cancer Studies (17 papers), Colorectal Cancer Surgical Treatments (9 papers) and Colorectal and Anal Carcinomas (9 papers). S. Chapet is often cited by papers focused on Head and Neck Cancer Studies (17 papers), Colorectal Cancer Surgical Treatments (9 papers) and Colorectal and Anal Carcinomas (9 papers). S. Chapet collaborates with scholars based in France, Switzerland and Germany. S. Chapet's co-authors include G. Calais, Y. Pointreau, M. Alfonsi, C. Sire, C. Tuchais, J. Tortochaux, Sandrine Faivre, A. Reynaud-Bougnoux, P. Garaud and O. Le Floch and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

S. Chapet

48 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Trial of Induction Chemotherapy With Cisplatin and 5-Fluorouracil With or Without Docetaxel for Larynx Preservation

2009 369 citations Y. Pointreau, S. Chapet et al. JNCI Journal of the National Cancer Institute profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Chapet France	14	603	511	506	495	178	48	1.3k
Nicolas Daly‐Schveitzer France	20	480 0.8×	476 0.9×	472 0.9×	535 1.1×	73 0.4×	52	1.4k
Jasna Aleksandrovic Serbia	17	411 0.7×	389 0.8×	544 1.1×	633 1.3×	203 1.1×	25	1.2k
Federico L. Ampil United States	20	372 0.6×	184 0.4×	447 0.9×	447 0.9×	180 1.0×	115	1.1k
W.M. Mendenhall United States	17	635 1.1×	633 1.2×	490 1.0×	336 0.7×	130 0.7×	53	1.3k
Parvesh Kumar United States	20	364 0.6×	506 1.0×	423 0.8×	540 1.1×	113 0.6×	43	1.2k
Karen D. Schupak United States	18	326 0.5×	378 0.7×	243 0.5×	518 1.0×	132 0.7×	25	943
Fadıl Akyol Türkiye	20	367 0.6×	401 0.8×	297 0.6×	615 1.2×	164 0.9×	65	1.1k
Lisa Zuraw Canada	10	497 0.8×	200 0.4×	682 1.3×	613 1.2×	243 1.4×	14	1.4k
Gregory J. Kubicek United States	22	334 0.6×	355 0.7×	276 0.5×	474 1.0×	99 0.6×	73	1.1k
Richard J. Cassidy United States	19	282 0.5×	166 0.3×	405 0.8×	502 1.0×	115 0.6×	50	934

Countries citing papers authored by S. Chapet

Since Specialization

Citations

This map shows the geographic impact of S. Chapet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Chapet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Chapet more than expected).

Fields of papers citing papers by S. Chapet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Chapet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Chapet. The network helps show where S. Chapet may publish in the future.

Co-authorship network of co-authors of S. Chapet

This figure shows the co-authorship network connecting the top 25 collaborators of S. Chapet. A scholar is included among the top collaborators of S. Chapet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Chapet. S. Chapet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Perrier, Lionel, Frédéric Balusson, J. Castelli, et al.. (2024). Cost-effectiveness of weekly adaptive radiotherapy versus standard IMRT in head and neck cancer alongside the ARTIX trial. Radiotherapy and Oncology. 193. 110116–110116. 4 indexed citations

Pointreau, Y., et al.. (2023). Stereotactic body radiotherapy for mediastinal lymph node with CyberKnife®: Efficacy and toxicity. Cancer/Radiothérapie. 27(3). 225–232. 2 indexed citations

Castelli, J., Juliette Thariat, Karen Bénézery, et al.. (2023). Weekly Adaptive Radiotherapy vs Standard Intensity-Modulated Radiotherapy for Improving Salivary Function in Patients With Head and Neck Cancer. JAMA Oncology. 9(8). 1056–1056. 31 indexed citations

Thariat, Juliette, M. Bosset, Alexandre Falcoz, et al.. (2023). 853O OMITting frontline chemotherapy in head and neck cancer (HNSCC) patients with 1-3 oligometastases using stereotactic ablative radiotherapy (SABR), the GORTEC 2014-04 “OMET” randomized phase II trial. Annals of Oncology. 34. S554–S554. 5 indexed citations

Blanc, Ellen, Anne Ducassou, A. Huchet, et al.. (2021). Hypofractionated stereotactic body radiation therapy (SBRT) in pediatric patients: preliminary toxicity results of a national prospective multicenter study. British Journal of Radiology. 94(1125). 20210176–20210176. 8 indexed citations

Müller, Olivier, Nicolas Tabchouri, Driffa Moussata, et al.. (2021). Prognostic Impact of Upfront Surgery for Locally Advanced Upper Rectal Adenocarcinoma. Anticancer Research. 42(1). 155–164. 2 indexed citations

Tabchouri, Nicolas, Gilles Manceau, Alice Frontali, et al.. (2020). Neoadjuvant Treatment in Upper Rectal Cancer Does Not Improve Oncologic Outcomes But Increases Postoperative Morbidity. Anticancer Research. 40(6). 3579–3587. 13 indexed citations

Scher, Nathaniel, P. Garaud, É. Chajon, et al.. (2019). Radiothérapie en conditions stéréotaxiques du carcinome hépatocellulaire : résultats d’une étude rétrospective multicentrique. Cancer/Radiothérapie. 23(2). 104–115. 5 indexed citations

Laprie, Anne, Anne Ducassou, Stéphanie Bolle, et al.. (2018). Re-irradiation of locally recurrent pediatric intracranial ependymoma: Experience of the French society of children’s cancer. Radiotherapy and Oncology. 132. 1–7. 19 indexed citations

10.

Chapet, S., et al.. (2015). Résultats à long terme de la chimioradiothérapie néoadjuvante des cancers de l’œsophage : étude rétrospective monocentrique sur 102 patients. Cancer/Radiothérapie. 19(5). 322–330. 1 indexed citations

11.

Destrieux, Christophe, et al.. (2014). Radionecrosis of malignant glioma and cerebral metastasis: A diagnostic challenge in MRI. Diagnostic and Interventional Imaging. 95(10). 985–1000. 37 indexed citations

12.

Duchange, Nathalie, S. Chapet, Étienne Dorval, et al.. (2010). La réunion de concertation pluridisciplinaire : quelle place dans la décision médicale en cancérologie ?. Bulletin du Cancer. 97(2). 255–264. 20 indexed citations

13.

Carrié, C., Jacques Grill, Dominique Figarella‐Branger, et al.. (2009). Online Quality Control, Hyperfractionated Radiotherapy Alone and Reduced Boost Volume for Standard Risk Medulloblastoma: Long-Term Results of MSFOP 98. Journal of Clinical Oncology. 27(11). 1879–1883. 49 indexed citations

14.

Pointreau, Y., S. Chapet, C. Sire, et al.. (2009). Randomized Trial of Induction Chemotherapy With Cisplatin and 5-Fluorouracil With or Without Docetaxel for Larynx Preservation. JNCI Journal of the National Cancer Institute. 101(7). 498–506. 369 indexed citations breakdown →

15.

Pointreau, Y., S. Chapet, C. Sire, et al.. (2009). Évaluation à long terme de la voix et de la déglutition dans le cadre de l’essai de phase III randomisé de préservation laryngée 2000–01 du Gortec. Cancer/Radiothérapie. 13(6-7). 680–680. 1 indexed citations

16.

Bénéton, Maud, S. Chapet, Hélène Blasco, et al.. (2007). Relationship between 5‐fluorouracil exposure and outcome in patients receiving continuous venous infusion with or without concomitant radiotherapy. British Journal of Clinical Pharmacology. 64(5). 613–621. 6 indexed citations

17.

Berger, Christine, A. De Muret, P. Garaud, et al.. (1997). Preoperative radiotherapy (RT) for rectal cancer: Predictive factors of tumor downstaging and residual tumor cell density (RTCD): Prognostic implications. International Journal of Radiation Oncology*Biology*Physics. 37(3). 619–627. 156 indexed citations

18.

Calais, G., Étienne Dorval, Pascal Bourlier, et al.. (1997). Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for stages IIB and III esophageal carcinoma: Results of a pilot study. International Journal of Radiation Oncology*Biology*Physics. 38(4). 769–775. 45 indexed citations

19.

Berger, Christine, et al.. (1996). Enhanced acute toxicity in oropharynx carcinoma treated with radiotherapy and concomitant cisplatin, 5-fluorouracil and mitomycin C. European Journal of Cancer. 32(10). 1707–1711. 5 indexed citations

20.

Chapet, S., Christine Berger, A Fignon, et al.. (1995). Abdomino pelvic irradiation after second-look laparotomy for stage III ovarian carcinoma. European Journal of Obstetrics & Gynecology and Reproductive Biology. 62(1). 43–48. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact